NP/PA Connect

News
Media
Conferences
Events
Publication
CME/CE
Resources
Editorial Advisory Board
Partners
Subscribe

Opinion|Videos|August 23, 2023

Importance of Long-Term Safety Data in Plaque Psoriasis Treatment

Author(s)Alexa Hetzel, MS, PA-C, Jennifer Conner, MPAS, PA-C, Terry Faleye, MPAS, PA-C

Lakshi Aldredge, MSN, ANP-BC, comments on the implications of long-term safety data in patients who may not have responded to initial treatment of plaque psoriasis.

Episodes in this series

EP. 1 The Role of Nurse Practitioners and Physician Assistants in Managing Plaque Psoriasis

EP. 1 The Role of Nurse Practitioners and Physician Assistants in Managing Plaque Psoriasis

EP. 2 Evolution of Plaque Psoriasis

EP. 2 Evolution of Plaque Psoriasis

EP. 3 Efficacy of Deucravacitinib in Plaque Psoriasis

EP. 3 Efficacy of Deucravacitinib in Plaque Psoriasis

EP. 4 Approaches to Treatment of Plaque Psoriasis

EP. 4 Approaches to Treatment of Plaque Psoriasis

EP. 5 Importance of Quick Response to Treatment for Patients With Plaque Psoriasis

EP. 5 Importance of Quick Response to Treatment for Patients With Plaque Psoriasis

EP. 6 Metrics to Determine Disease Clearance in Plaque Psoriasis

EP. 6 Metrics to Determine Disease Clearance in Plaque Psoriasis

EP. 7 Addressing Unmet Needs in Psoriasis Treatment

EP. 7 Addressing Unmet Needs in Psoriasis Treatment

EP. 8 Patient Case #1: 50-Year-Old Female With Plaque Psoriasis

EP. 8 Patient Case #1: 50-Year-Old Female With Plaque Psoriasis

EP. 9 Escalating Treatment From Topical to Systemic in Plaque Psoriasis

EP. 9 Escalating Treatment From Topical to Systemic in Plaque Psoriasis

EP. 10 Systemic Treatment Options in Plaque Psoriasis

EP. 10 Systemic Treatment Options in Plaque Psoriasis

EP. 11 Importance of Long-Term Safety Data in Plaque Psoriasis Treatment

EP. 11 Importance of Long-Term Safety Data in Plaque Psoriasis Treatment

EP. 12 Patient Case #2: 23-Year-Old Female With Plaque Psoriasis

EP. 12 Patient Case #2: 23-Year-Old Female With Plaque Psoriasis

EP. 13 Use of Systemic Treatment in Plaque Psoriasis

EP. 13 Use of Systemic Treatment in Plaque Psoriasis

EP. 14 Safety Profile of TYK2 Inhibitors in Plaque Psoriasis Treatment

EP. 15 Role of Advanced Practice Providers in Plaque Psoriasis Treatment Follow-Up

EP. 15 Role of Advanced Practice Providers in Plaque Psoriasis Treatment Follow-Up

EP. 16 Patient Case #3: 40-Year-Old Woman With a 10-Year History of Plaque Psoriasis

EP. 16 Patient Case #3: 40-Year-Old Woman With a 10-Year History of Plaque Psoriasis

EP. 17 Treating Comorbidities With Plaque Psoriasis

EP. 17 Treating Comorbidities With Plaque Psoriasis

EP. 18 Unmet Needs in the Treatment Spectrum of Plaque Psoriasis

EP. 18 Unmet Needs in the Treatment Spectrum of Plaque Psoriasis

EP. 19 Take-Home Pearls on the Management of Plaque Psoriasis

EP. 19 Take-Home Pearls on the Management of Plaque Psoriasis

Newsletter

Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.

Related Content

Oruka Reports Positive Interim Phase 1 Data for ORKA-002, Advances ORKA-001

ByMaddi Hebebrand, MC, Associate Editor

January 12th 2026

Precision Dermatology: Aligning Immune Pathways with Therapy

ByMaddi Hebebrand, MC, Associate Editor

January 6th 2026

Phase 3 Data Support Oral TYK2 Inhibitor Envudeucitinib for Psoriasis

ByMaddi Hebebrand, MC, Associate Editor

January 6th 2026

New Study Reveals High Rates of Addiction Among Patients with Psoriasis and Other Conditions

ByMarie Bosslett, Assistant Editor

January 6th 2026

French Guidelines Updated to Reflect Advances in Systemic Psoriasis Therapy

ByMaddi Hebebrand, MC, Associate Editor

January 3rd 2026

Latest CME

Medical Crossfire®: Navigating Chronic GVHD Prophylaxis and Treatment – Targeted Strategies to Elevate Patient Outcomes

Medical Crossfire®: Navigating Chronic GVHD Prophylaxis and Treatment – Targeted Strategies to Elevate Patient Outcomes

Corey Cutler, MD, MPH, FRCP(C); Amin M. Alousi, MD; Mehdi Hamadani, MD; Anna Sureda, MD, PhD

Expert Illustrations & Commentaries™: Exploring Novel Therapeutic Targets in Acne Management

Expert Illustrations & Commentaries™: Exploring Novel Therapeutic Targets in Acne Management

Hilary Baldwin; Neal Bhatia, MD

Burst CME: Targeted Therapy for Optimal Psoriasis Management

Burst CME: Targeted Therapy for Optimal Psoriasis Management

Tina Bhutani, MD

Revolutionizing Atopic Dermatitis (RAD) Conference 2026

In-Person Event

Revolutionizing Atopic Dermatitis (RAD) Conference 2026

June 17-19, 2026

Understanding Topical Steroid Withdrawal (TSW) in Patients With Atopic Dermatitis (AD)

Understanding Topical Steroid Withdrawal (TSW) in Patients With Atopic Dermatitis (AD)

Diego Ruiz Dasilva, MD, FAAD; Brad Glick, DO, MPH. FAAD; Peter Lio, MD

Clinical Consultations™: Providing Holistic Care for Complex Cases of Psoriasis with Cardiovascular Comorbidities

Clinical Consultations™: Providing Holistic Care for Complex Cases of Psoriasis with Cardiovascular Comorbidities

Brittany Weber MD, PhD, FACC, FAHA; Lourdes M. Perez-Chada MD, MMSc

Navigating Safety Data with Janus Kinase (JAK) Inhibitors in Atopic Dermatitis (AD) Management

Navigating Safety Data with Janus Kinase (JAK) Inhibitors in Atopic Dermatitis (AD) Management

Andrew Alexis, MD, MPH; Leon Kircik, MD

Assessing the Evidence for OX40-OX40L Axis Inhibition for the Treatment of Atopic Dermatitis

Assessing the Evidence for OX40-OX40L Axis Inhibition for the Treatment of Atopic Dermatitis

Johann Gudjonsson, MD, PhD; Christopher Bunick, MD, PhD

Burst CME™: Optimizing Care for Patients with Psoriasis – Incorporating a Buy-and-Bill Model for Biologic Agents into Dermatological Practice

Burst CME™: Optimizing Care for Patients with Psoriasis – Incorporating a Buy-and-Bill Model for Biologic Agents into Dermatological Practice

Jerry Bagel, MD, MS

Cases and Conversations™: Biologic Matchmaking in Psoriasis – Finding the Right Therapy for the Right Patient

Cases and Conversations™: Biologic Matchmaking in Psoriasis – Finding the Right Therapy for the Right Patient

Douglas DiRuggiero, DMSc, MHS, PA-C; Lakshi Aldredge, MSN, ANP-BC, DCNP, FAANP

Patient, Provider, and Caregiver Connection™: Addressing Patient Challenges With Holistic Approaches to Vitiligo Management

Patient, Provider, and Caregiver Connection™: Addressing Patient Challenges With Holistic Approaches to Vitiligo Management

Andrew F. Alexis, MD, MPH; Chesahna Kindred, MD, MBA, FAAD

Hidradenitis Suppurativa: Diving Deeper Into Disease Pathogenesis, Severity Assessment, and Holistic Management Approaches

Hidradenitis Suppurativa: Diving Deeper Into Disease Pathogenesis, Severity Assessment, and Holistic Management Approaches

Hadar Lev-Tov, MD; Martina Porter, MD

Derm Nexus The Inflammatory Disease and Innovations Congress for NP/PAs

In-Person Event

Derm Nexus The Inflammatory Disease and Innovations Congress for NP/PAs

November 19-21, 2026

Clear Skin, Clear Mind: Integrating Mental Health into Psoriasis Care

Clear Skin, Clear Mind: Integrating Mental Health into Psoriasis Care

John Koo, MD; T.J. Chao, MPAS, PA-C

Trending on Dermatology Times

Phase 2a Evaluation of Dual OX40L/TNFα Antibody Begins in HS

Eli Lilly Trial Shows Superior Outcomes With Ixekizumab and Tirzepatide in Patients With PsA and Obesity

FDA Feedback Supports BLA Pathway for Sonelokimab in HS

Interim Analysis Leads to Early Termination of DUPLEX-AD Study

Top 5 Articles of the Week: January 4-9